BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 7066526)

  • 21. [Characteristics of T-suppressors responsible for the competition between cellular and humoral immune response in the spleen].
    Gusev EIu; Kevorkov NN
    Biull Eksp Biol Med; 1993 Mar; 115(3):287-9. PubMed ID: 8054627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biochemical studies of immune RNA using a cell-mediated cytotoxicity assay.
    Griffin GD; Sellin HG; Novelli GD
    Cancer Biochem Biophys; 1980; 4(3):123-31. PubMed ID: 6159963
    [No Abstract]   [Full Text] [Related]  

  • 23. [The immunocorrective activity of myelopeptide-1 and myelopeptide-2 in cyclophosphane-treated mice].
    Shanurin SIu; Belevskaia RG; Mikhaĭlova AA; Shanurin MIu
    Eksp Klin Farmakol; 1995; 58(5):53-6. PubMed ID: 8704592
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparison of cellular immune changes in the draining paraaortic lymph nodes in syngeneic and allogeneic pregnancies.
    Gottesman SR; Stutman O
    Prog Clin Biol Res; 1981; 70():121-36. PubMed ID: 6458821
    [No Abstract]   [Full Text] [Related]  

  • 25. Inhibition by selected anticancer agents of the development of primary cell-mediated immunity against allogeneic tumor cells in culture.
    Orsini F; Eppolito C; Ehrke MJ; Mihich E
    Cancer Treat Rep; 1980; 64(2-3):211-8. PubMed ID: 6967756
    [No Abstract]   [Full Text] [Related]  

  • 26. Purified hepatic parenchymal cells are nonimmunogenic in vitro.
    Karrer FM; Gill R; Ostrowska A; Bolwerk A; Reitz B; Stegall M; Schroter G; Kam I; Lafferty KJ
    Transplant Proc; 1995 Feb; 27(1):625-7. PubMed ID: 7879124
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effect of various dietary fat-carbohydrate ratios on the immunological response of mice].
    Lebengarts IaZ; Berezina TA
    Vopr Pitan; 1973; 32(3):38-40. PubMed ID: 4798575
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of IL-12 on the response and susceptibility to experimental viral infections.
    Orange JS; Wolf SF; Biron CA
    J Immunol; 1994 Feb; 152(3):1253-64. PubMed ID: 7905500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunosuppressive effect of stepronin (TS-5010680) in mice.
    de Giorgi L; Arrigoni-Martelli E; Matossian-Rogers A
    Transplant Proc; 1994 Dec; 26(6):3513-6. PubMed ID: 7998255
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effect of splenectomy on immunologic reactivity (review of the literature)].
    Pavlovskiĭ MP; Chuklin SN; Orel GL
    Khirurgiia (Mosk); 1986 Jun; (6):136-41. PubMed ID: 3528631
    [No Abstract]   [Full Text] [Related]  

  • 31. [Correction of anti-tumor immunity by beta-carotene during experimental chemotherapy of malignant neoplasms].
    Ramanauskaĭte RIu; Abronina IF; Karaseva LI; Sergeev AV
    Biull Eksp Biol Med; 1994 Sep; 118(9):295-7. PubMed ID: 7819566
    [No Abstract]   [Full Text] [Related]  

  • 32. [Analysis of nonspecific cytotoxicity induced by immunization with allogeneic cells and its significance in cellular immunity (author's transl)].
    Yano Y
    Fukuoka Igaku Zasshi; 1980 Mar; 71(3):107-21. PubMed ID: 7380382
    [No Abstract]   [Full Text] [Related]  

  • 33. Augmenting major histocompatibility complex class I expression by murine tumors in vivo enhances antitumor immunity induced by an active immunotherapy strategy.
    Merritt RE; Yamada RE; Crystal RG; Korst RJ
    J Thorac Cardiovasc Surg; 2004 Feb; 127(2):355-64. PubMed ID: 14762342
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of immune effector cell cytolytic activity and tumour growth inhibition in vivo by Ukrain (NSC 631570).
    Liepins A; Nowicky JW
    Drugs Exp Clin Res; 1996; 22(3-5):103-13. PubMed ID: 8899312
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spontaneous cytotoxicity of murine cells treated with the interferon inducers BRL 5907 and BRL 10739.
    Cook RM
    Immunology; 1980 Feb; 39(2):151-7. PubMed ID: 7380465
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Metabolic and functional changes in the spleen during reparative regeneration following pharmacological damage].
    Svirnovskiĭ AI; Shimanskaia TV; Levin VI; Medved' IN; Tsygankov VG
    Patol Fiziol Eksp Ter; 1982; (3):31-6. PubMed ID: 6889724
    [No Abstract]   [Full Text] [Related]  

  • 37. Analysis of the mechanism of allograft rejection and cell-mediated immunity. I. Accelerated rejection of tumour allografts without augmented cytotoxicity in the spleen cells.
    Nanishi F; Nomoto K; Taniguchi K; Kubo C
    Immunology; 1980 May; 40(1):67-76. PubMed ID: 7419243
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of immunotoxicity induced by diazinon in C57bl/6 mice.
    Neishabouri EZ; Hassan ZM; Azizi E; Ostad SN
    Toxicology; 2004 Mar; 196(3):173-9. PubMed ID: 15036744
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The immunotropic activity of erakond].
    Lukmanova KA; Fridman SM; Valishin DA; Trofimov VA; Kireeva RM; Nasyrov KhM; Nigmatullin TG
    Eksp Klin Farmakol; 1998; 61(4):41-3. PubMed ID: 9783108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Humoral immune response in experimental animals exposed to organic and inorganic compounds].
    Mikhaĭlova IV; Kislinskaia ES; Pushkareva LA; Rumiantseva AV
    Gig Sanit; 2009; (4):73-5. PubMed ID: 19799230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.